Tweet Disematkan
SPEAR
5 posts
SPEAR
@SPEARstudy
Research on doxyPEP to prevent sexually transmitted infections, antimicrobial resistance & microbiome. Led by Dr Manik Kohli @UCL_CRISH. Funders NIHR/BHIVA/BIA.
United Kingdom Bergabung Şubat 2024
92 Mengikuti10 Pengikut
SPEAR me-retweet
Out today - We looked at doxyPEP uptake among >11,000 PrEP users at Kaiser Permanente Northern California.. 1 in 5 started #doxyPEP within a year of availability, and STI incidence declined following uptake. Prescribing DoxyPEP outside of clinical trials reduces STIs.
JAMA Internal Medicine@JAMAInternalMed
Receipt of doxyPEP was associated with substantial declines in chlamydia and syphilis incidence and modest declines in urethral and rectal gonorrhea incidence among individuals using HIV PrEP. ja.ma/41VQmVQ
English
SPEAR me-retweet
We are open for recruitment! The
@SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. Visit doxypep.me/spear
English
We are open for recruitment! The @SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. More details below doxypep.me/spear
English